PHAC explains reason for pulling COVID-19 vaccines before new ones approved

1 week ago 10

Author of the article:

Canadian Press

Hannah Alberga

Published Sep 10, 2024 • 1 minute read

Jars full of empty COVID-19 vaccine vials

The Public Health Agency of Canada says it asked provinces to get rid of existing COVID-19 vaccines to avoid confusion with new formulations that will have the same drug identification number.

Advertisement 2

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

Unlimited online access to articles from across Canada with one account.
Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on.
Enjoy insights and behind-the-scenes analysis from our award-winning journalists.
Support local journalists and the next generation of journalists.
Daily puzzles including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

Unlimited online access to articles from across Canada with one account.
Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on.
Enjoy insights and behind-the-scenes analysis from our award-winning journalists.
Support local journalists and the next generation of journalists.
Daily puzzles including the New York Times Crossword.

Create an account or sign in to continue with your reading experience.

Access articles from across Canada with one account.
Share your thoughts and join the conversation in the comments.
Enjoy additional articles per month.
Get email updates from your favourite authors.

Article content

Health Canada says it is reviewing updated COVID-19 vaccines that essentially modify the current shot to target a more recent strain of the virus for an expected fall rollout.

That’s opposed to waiting for an entirely new formulation that would carry a different number but take longer to develop from scratch and slow down the approval process.

PHAC’s vice-president of infectious diseases and vaccination programs branch is explaining the plan after some pharmacists and doctors said it could leave gaps in vaccine access that could span weeks.

Dr. Donald Sheppard says this is the practice with other regularly updated vaccines, including those for influenza.

Sheppard says we’ve entered a similarly routine phase for COVID-19 vaccinations, noting the past several shots have been updated versions of previous formulations.

The federal agency released a directive to provinces and territories last month to dispose of vaccine stocks that target the previously-dominant XBB.1.5 variant, before formulations targeting JN.1 or KP.2 are approved and distributed.

Article content

*** Disclaimer: This Article is auto-aggregated by a Rss Api Program and has not been created or edited by Bdtype.

(Note: This is an unedited and auto-generated story from Syndicated News Rss Api. News.bdtype.com Staff may not have modified or edited the content body.

Please visit the Source Website that deserves the credit and responsibility for creating this content.)

Watch Live | Source Article